Benitec Biopharma (BNTC) reported a net loss of $12.9 million, or $0.26 per basic and diluted share, for the fiscal first quarter ended September 30, 2026. The company had $176.5 million in cash and cash equivalents at quarter-end.
The company also reported interim Phase 1b/2a data for BB-301 in OPMD-related dysphagia, with a 100% responder rate across Cohort 1 and Cohort 2 patients. Benitec said it expects to finalize the pivotal-study design in the first calendar quarter of 2027 and begin the trial in mid-2027.
- Total operating expenses were $14.5 million, including $8.6 million in research and development expense.
- Net loss was $12.925 million, compared with $8.965 million in the prior-year quarter.
- Basic and diluted net loss per share was $0.26, compared with $0.22 a year earlier.
- Benitec plans to change its fiscal year-end from June 30 to December 31.
- No serious adverse events have been reported in patients treated with BB-301 to date.
$BNTC Hedge Fund Activity
We have seen 41 institutional investors add shares of $BNTC stock to their portfolio, and 37 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 269,235 shares (+41.3%) to their portfolio in Q2 2026, for an estimated $3,602,364
- SILVERARC CAPITAL MANAGEMENT, LLC removed 236,717 shares (-34.8%) from their portfolio in Q3 2026, for an estimated $2,367,170
- BLACKROCK, INC. added 221,397 shares (+18.7%) to their portfolio in Q2 2026, for an estimated $2,962,291
- LONGAEVA PARTNERS L.P. removed 110,126 shares (-88.1%) from their portfolio in Q2 2026, for an estimated $1,473,485
- RUSSELL INVESTMENTS GROUP, LTD. removed 106,656 shares (-82.7%) from their portfolio in Q3 2026, for an estimated $1,066,560
- AMERIPRISE FINANCIAL INC added 82,899 shares (+26.0%) to their portfolio in Q2 2026, for an estimated $1,109,188
- SCHONFELD STRATEGIC ADVISORS LLC added 82,178 shares (+53.6%) to their portfolio in Q2 2026, for an estimated $1,099,541
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.